CTI BioPharma Corp.
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhi…
Biotechnology
US, Seattle [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
CTI BioPharma Corp. has no acquisition track records yet.
M&A Deals · History
CTI BioPharma Corp. has no acquisition track records yet.